Cancer stem cells niche: a target for novel cancer therapeutics
- PMID: 23219150
- DOI: 10.1016/j.ctrv.2012.10.004
Cancer stem cells niche: a target for novel cancer therapeutics
Abstract
Nowadays, cancer has been a frequent disease, and the first or second most common cause of death worldwide. Despite a better understanding of the biology of cancer cells, the therapy of most cancers has not significantly changed for the past four decades. It is because conventional chemotherapies and/or radiation therapies are usually designed to eradicate highly proliferative cells. Mounting evidence has implicated that cancer is a disease of stem cells. Cancer stem cells (CSC) are often relatively quiescent, and therefore may not be affected by therapies targeting rapidly dividing cells. Like normal stem cells (NSC) residing in a "stem cell niche" that maintains them in a stem-like state, CSC also require a special microenvironment to control their self-renewal and undifferentiated state. The "CSC niche" is likely to be the most crucial target in the treatment of cancer. In this article, we summarize the current knowledge regarding CSC and their niche microenvironments. Understanding of CSC's origin, molecular profile, and interaction with their microenvironments, this could be a paradigm shift in the treatment of cancer, away from targeting the blast cells and towards the targeting of the CSC, thus improving therapeutic outcome.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
Cancer stem cells and angiogenesis.Int J Dev Biol. 2011;55(4-5):477-82. doi: 10.1387/ijdb.103225yz. Int J Dev Biol. 2011. PMID: 21732274 Review.
-
Cancer stem cell niche: the place to be.Cancer Res. 2011 Feb 1;71(3):634-9. doi: 10.1158/0008-5472.CAN-10-3220. Epub 2011 Jan 25. Cancer Res. 2011. PMID: 21266356 Review.
-
The stem cell niche in health and malignancy.Semin Cancer Biol. 2010 Apr;20(2):107-15. doi: 10.1016/j.semcancer.2010.05.006. Epub 2010 May 25. Semin Cancer Biol. 2010. PMID: 20510363 Review.
-
An alginate-based platform for cancer stem cell research.Acta Biomater. 2016 Jun;37:83-92. doi: 10.1016/j.actbio.2016.04.032. Epub 2016 Apr 19. Acta Biomater. 2016. PMID: 27109764
-
Cancer stem cells: never Wnt away from the niche.Curr Opin Oncol. 2009 Jan;21(1):41-6. doi: 10.1097/CCO.0b013e32831d1faf. Curr Opin Oncol. 2009. PMID: 19125017 Review.
Cited by
-
TNF-α induced epithelial mesenchymal transition increases stemness properties in renal cell carcinoma cells.Int J Clin Exp Med. 2014 Dec 15;7(12):4951-8. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 25663992 Free PMC article.
-
Downstream Targets of VHL/HIF-α Signaling in Renal Clear Cell Carcinoma Progression: Mechanisms and Therapeutic Relevance.Cancers (Basel). 2023 Feb 19;15(4):1316. doi: 10.3390/cancers15041316. Cancers (Basel). 2023. PMID: 36831657 Free PMC article. Review.
-
Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance.Stem Cell Rev Rep. 2020 Apr;16(2):397-412. doi: 10.1007/s12015-019-09942-y. Stem Cell Rev Rep. 2020. PMID: 31965409 Review.
-
Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2.Int J Mol Sci. 2017 Sep 15;18(9):1986. doi: 10.3390/ijms18091986. Int J Mol Sci. 2017. PMID: 28914785 Free PMC article.
-
Alpha-enolase (ENO1), identified as an antigen to monoclonal antibody 12C7, promotes the self-renewal and malignant phenotype of lung cancer stem cells by AMPK/mTOR pathway.Stem Cell Res Ther. 2021 Feb 12;12(1):119. doi: 10.1186/s13287-021-02160-9. Stem Cell Res Ther. 2021. PMID: 33579362 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
